⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
XLO News
Xilio Therapeutics, Inc. Common Stock
Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates
globenewswire.com
XLO
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
XLO
Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2
globenewswire.com
XLO
Form 8-K
sec.gov
XLO
Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors
globenewswire.com
XLO
ANIK
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
XLO
Form 8-K
sec.gov
XLO
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
XLO
Xilio Therapeutics to Present New Preclinical Data for its Masked T Cell Engager Program Targeting CLDN18.2 at the American Association for Cancer Research (AACR) Annual Meeting
globenewswire.com
XLO
Form 8-K
sec.gov
XLO